Deal Announcements

Roka BioScience Nets $20 Million Venture Capital

Friday, July 29, 2011 5:30:00 AM PDT | VentureDeal Staff

San Diego, California  --  Biotechnology company Roka BioScience has garnered $20 million in its third round of institutional venture capital investment.

Roka is developing rapid molecular assays and instrument systems for industrial applications focused on the food safety industry.

Investors in the round included OrbiMed, New Enterprise Associates, TPG Biotech and Gen-Probe.

The company said it was on track to commercialize its first assay later this year.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1